Can the treatment of sleep apnea syndrome prevent the cardiovascular consequences?

被引:10
作者
Fletcher, EC [1 ]
机构
[1] VET AFFAIRS MED CTR,DEPT MED,DIV RESP CRIT CARE & ENVIRONM MED,LOUISVILLE,KY
关键词
sleep apnea; blood pressure; nasal CPAP; weight loss; hypertension;
D O I
10.1093/sleep/19.suppl_9.S67
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
He et al. indicated that mortality is reduced in treated patients with OSA but the reasons for this are still speculative. CPAP eliminates the acute elevation of blood pressure (BP) that occurs during a night of obstructive apneas. In longer term studies hypertensive patients showed a fall in mean BP from baseline with CPAP both by day and by night. Noncompliant patients do not achieve this benefit and BP does not change in normotensive patients with OSA on CPAP. On the other hand, left ventricular mass does not seem to change in hypertensive OSA patients despite reduction in blood pressure. Some of the benefit in BP reduction may relate to other interventions such as successful weight loss. Clear answers as to the effects of intervention are difficult because of confounding factors such as antihypertensive medication and length of follow up as well as questions of compliance with treatment. Multicenter trials are being currently undertaken but will need some years to yield answers.
引用
收藏
页码:S67 / S70
页数:4
相关论文
共 9 条
[1]   THE ACUTE EFFECTS OF CONTINUOUS POSITIVE AIRWAY PRESSURE AND OXYGEN ADMINISTRATION ON BLOOD-PRESSURE DURING OBSTRUCTIVE SLEEP-APNEA [J].
ALI, NJ ;
DAVIES, RJO ;
FLEETHAM, JA ;
STRADLING, JR .
CHEST, 1992, 101 (06) :1526-1532
[2]   AMBULATORY BLOOD-PRESSURE AND LEFT-VENTRICULAR HYPERTROPHY IN SUBJECTS WITH UNTREATED OBSTRUCTIVE SLEEP-APNEA AND SNORING, COMPARED WITH MATCHED CONTROL SUBJECTS, AND THEIR RESPONSE TO TREATMENT [J].
DAVIES, RJO ;
CROSBY, J ;
PROTHERO, A ;
STRADLING, JR .
CLINICAL SCIENCE, 1994, 86 (04) :417-424
[3]   MORTALITY AND APNEA INDEX IN OBSTRUCTIVE SLEEP-APNEA - EXPERIENCE IN 385 MALE-PATIENTS [J].
HE, J ;
KRYGER, MH ;
ZORICK, FJ ;
CONWAY, W ;
ROTH, T .
CHEST, 1988, 94 (01) :9-14
[4]   BLOOD-PRESSURE, CATECHOLAMINES, AND PANCREATIC-POLYPEPTIDE IN OBSTRUCTIVE SLEEP-APNEA WITH AND WITHOUT NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE (NCPAP) TREATMENT [J].
JENNUM, P ;
WILDSCHIODTZ, G ;
CHRISTENSEN, NJ ;
SCHWARTZ, T .
AMERICAN JOURNAL OF HYPERTENSION, 1989, 2 (11) :847-852
[5]   BLOOD-PRESSURE AND SLEEP-APNEA - RESULTS OF LONG-TERM NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY [J].
MAYER, J ;
BECKER, H ;
BRANDENBURG, U ;
PENZEL, T ;
PETER, JH ;
VONWICHERT, P .
CARDIOLOGY, 1991, 79 (02) :84-92
[6]   NASAL CPAP AND WEIGHT-LOSS IN HYPERTENSIVE PATIENTS WITH OBSTRUCTIVE SLEEP-APNEA [J].
RAUSCHER, H ;
FORMANEK, D ;
POPP, W ;
ZWICK, H .
THORAX, 1993, 48 (05) :529-533
[7]   LONG-TERM NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE ADMINISTRATION CAN NORMALIZE HYPERTENSION IN OBSTRUCTIVE SLEEP-APNEA PATIENTS [J].
SUZUKI, M ;
OTSUKA, K ;
GUILLEMINAULT, C .
SLEEP, 1993, 16 (06) :545-549
[8]   EFFECT OF NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE DURING SLEEP ON 24-HOUR BLOOD-PRESSURE IN OBSTRUCTIVE SLEEP-APNEA [J].
WILCOX, I ;
GRUNSTEIN, RR ;
HEDNER, JA ;
DOYLE, J ;
COLLINS, FL ;
FLETCHER, PJ ;
KELLY, DT ;
SULLIVAN, CE .
SLEEP, 1993, 16 (06) :539-544
[9]  
WORSNOP CJ, 1993, SLEEP, V6, pS148